ArticleTrials2022

IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).

Zahra Nochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.